Groupe la Francaise Buys Shares of 126,000 LENSAR, Inc. $LNSR

Key Points

• Groupe la Francaise has acquired a new stake in LENSAR, Inc., purchasing 126,000 shares valued at approximately $1.78 million, increasing their ownership to about 1.07% as of the end of the most recent quarter.
• Other hedge funds have also invested in LENSAR, resulting in 40.15% of the stock being owned by institutional investors.
• Despite the investments, LENSAR reported disappointing quarterly earnings, missing revenue estimates and showing a negative return on equity of 737.30%.

Groupe la Francaise acquired a new position in shares of LENSAR, Inc. (NASDAQ:LNSR - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 126,000 shares of the company's stock, valued at approximately $1,779,000. Groupe la Francaise owned about 1.07% of LENSAR at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Nuveen LLC acquired a new stake in LENSAR during the first quarter worth about $252,000. Virtu Financial LLC acquired a new stake in LENSAR during the first quarter worth about $407,000. Tabor Asset Management LP acquired a new stake in LENSAR during the first quarter worth about $452,000. Draper Asset Management LLC acquired a new stake in LENSAR during the first quarter worth about $565,000. Finally, Geode Capital Management LLC increased its position in LENSAR by 5.6% during the fourth quarter. Geode Capital Management LLC now owns 106,058 shares of the company's stock worth $948,000 after purchasing an additional 5,627 shares during the last quarter. 40.15% of the stock is currently owned by institutional investors and hedge funds.

LENSAR Trading Down 0.3%

LENSAR stock traded down $0.04 during midday trading on Thursday, hitting $12.15. 121,516 shares of the stock were exchanged, compared to its average volume of 127,560. LENSAR, Inc. has a fifty-two week low of $3.80 and a fifty-two week high of $17.31. The stock has a market capitalization of $145.07 million, a price-to-earnings ratio of -2.89 and a beta of 0.50. The stock's 50-day simple moving average is $12.86 and its 200 day simple moving average is $13.17.

LENSAR (NASDAQ:LNSR - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by ($0.07). LENSAR had a negative return on equity of 737.30% and a negative net margin of 84.49%.The firm had revenue of $11.36 million for the quarter, compared to analyst estimates of $16.55 million.

About LENSAR

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.